A phase I trial of isolated hepatic perfusion (IHP) using 5-FU and oxaliplatin in patients with unresectable isolated liver metastases from colorectal cancer. [electronic resource]
Producer: 20131217Description: 2180-7 p. digitalISSN:- 1534-4681
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Area Under Curve
- Carcinoembryonic Antigen -- blood
- Chemotherapy, Cancer, Regional Perfusion -- adverse effects
- Colorectal Neoplasms -- blood
- Disease-Free Survival
- Female
- Fluorouracil -- administration & dosage
- Humans
- Kaplan-Meier Estimate
- Liver Neoplasms -- blood
- Male
- Maximum Tolerated Dose
- Middle Aged
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.